BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/2/2026 8:37:17 AM | Browse: 38 | Download: 96
 |
Received |
|
2025-10-16 13:19 |
|
Peer-Review Started |
|
2025-10-16 13:19 |
|
First Decision by Editorial Office Director |
|
2025-10-30 09:33 |
|
Return for Revision |
|
2025-10-30 09:33 |
|
Revised |
|
2025-11-13 08:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-05 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-06 02:11 |
|
Articles in Press |
|
2026-01-06 02:11 |
|
Edit the Manuscript by Language Editor |
|
2026-01-17 06:23 |
|
Typeset the Manuscript |
|
2026-02-11 09:25 |
|
Publish the Manuscript Online |
|
2026-03-02 08:37 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Editorial |
| Article Title |
Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Saeed Mohammadi, Mahmoud Darweesh and Ahmed Al-Harrasi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Oman Ministry of Higher Education, Research, and Innovation |
No. BFP/RGP/HSS/24/015 |
|
| Corresponding Author |
Ahmed Al-Harrasi, Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, PO Box 33, Nizwa 616, Ad Dakhiliyah, Oman. aharrasi@unizwa.edu.om |
| Key Words |
Growth differentiation factor 11; Macrophages; Immunometabolism; Macrophage polarization; Cancer; Tumor microenvironment; Hepatocellular carcinoma |
| Core Tip |
Growth differentiation factor 11 (GDF11) is a potent immunometabolic modulator that can reprogram pro-tumoral M2-like macrophages primarily studied in hepatocellular carcinoma. GDF11 reverses their dysfunctional metabolic state by activating Smad2/3 signaling, restoring mitochondrial oxidative phosphorylation (as indicated by increased oxygen consumption rate), and reducing immunosuppressive cellular cholesterol. This critical metabolic shift induces the production of anti-tumoral cytokines and reactive oxygen species, neutralizing tumor cell proliferation and migration. GDF11 could be a promising, mechanism-based strategy to flip the immune-suppressive microenvironment toward tumor destruction. |
| Publish Date |
2026-03-02 08:37 |
| Citation |
Mohammadi S, Darweesh M, Al-Harrasi A. Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy. World J Gastroenterol 2026; 32(10): 115371 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i10/115371.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i10.115371 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
